Sector: health
Conviction from: S&P
52-week range: 74.66108.00
Edwards Lifesciences designs and manufactures heart valves and hemodynamic monitoring devices, specializing in transcatheter and surgical treatments for structural heart disease and critical-care patients.
4 tracked filer(s) hold this · 0 opened, 1 added, 3 trimmed in 30-SEP-2026
Aggregate 13FScore 70 — mean of 4 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Bridgewater | 55 | Added +48% | 408,072 | $35,224,775 | 0.2% |
| David Rolfe / Wedgewood | 89 | Trimmed -9% | 151,007 | $13,034,924 | 2.8% |
| Steve Cohen / Point72 | 75 | Trimmed -49% | 905,585 | $78,170,097 | 0.1% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -80% | 6,200 | $535,184 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
5 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-07-01 | Trump, Donald J President | BUY | $50,001 - $100,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $100,001 - $250,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $500,001 - $1,000,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |